← Browse by Condition
Medical Condition

recurrent miscarriage

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for recurrent miscarriage sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 3
1
Top Sponsors
Jagiellonian University 1 trial
Assiut University 1 trial
Aalborg University Hospital 1 trial
Chinese University of Hong Kong 1 trial
NCT06826365
Recruiting

Immune Cell Populations in the Endometrium

Enrollment
50 pts
Location
Poland
Sponsor
Jagiellonian University
View Trial →
NCT06356792
Recruiting

Obstetrics , Prenatal Outcomes in Recurrent Miscarriage

Enrollment
102 pts
Location
Egypt
Sponsor
Assiut University
View Trial →
NCT05169541
Recruiting

Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction

Enrollment
500 pts
Location
Denmark
Sponsor
Aalborg University Hospital
View Trial →
NCT03902912 Phase 3
Recruiting

Effect of Prednisolone Treatment on Uterine Natural Killer Cells

Enrollment
84 pts
Location
Hong Kong
Sponsor
Chinese University of Hong Kon...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology